Phospholipase A2 as a "death trigger" in the aging process. The use of PLA2 inhibitors as antiaging substances.
Regelson
W
W
Department of Medicine, Medical College of Virginia/Virginia Commonwealth University, Richmond 23298-0001.
Franson
R
R
D000375:Aging / Q000187:drug effects / Q000502:physiology*; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D000975:Antioxidants / Q000494:pharmacology; D006801:Humans; D010741:Phospholipases A / Q000037:antagonists & inhibitors* / Q000502:physiology; D054467:Phospholipases A2; D011108:Polymers / Q000494:pharmacology*; D011456:Prostaglandins B / Q000494:pharmacology*; D011465:Prostaglandins, Synthetic / Q000494:pharmacology*
D000893:Anti-Inflammatory Agents; D000975:Antioxidants; D011108:Polymers; D011456:Prostaglandins B; D011465:Prostaglandins, Synthetic; C024303:prostaglandin Bx; D010741:Phospholipases A; D054467:Phospholipases A2